|
|
Volumn 18, Issue 3, 1992, Pages 515-542
|
|
Treatment of the neuroleptic-nonresponsive schizophrenic patient
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMANTADINE;
ANTIDEPRESSANT AGENT;
ANTIPARKINSON AGENT;
BENZODIAZEPINE DERIVATIVE;
CALCIUM CHANNEL BLOCKING AGENT;
CARBAMAZEPINE;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CLOZAPINE;
CREATINE KINASE;
DEXAMPHETAMINE;
DOPAMINE;
HALOPERIDOL;
LEVODOPA;
LITHIUM;
NEUROLEPTIC AGENT;
OPIATE;
PROLACTIN;
RESERPINE;
RITANSERIN;
SEROTONIN;
THIORIDAZINE;
VALPROIC ACID;
AGRANULOCYTOSIS;
ARTICLE;
CARDIOVASCULAR EFFECT;
DRUG CONTRAINDICATION;
DRUG EFFICACY;
DRUG METABOLISM;
DRUG RESISTANCE;
DRUG RESPONSE;
ELECTROCONVULSIVE THERAPY;
EXTRAPYRAMIDAL SYMPTOM;
GRAND MAL SEIZURE;
GRANULOCYTOPENIA;
HUMAN;
HYPERSALIVATION;
INTRAMUSCULAR DRUG ADMINISTRATION;
NEUROLEPTIC MALIGNANT SYNDROME;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
PSYCHOSURGERY;
REMISSION;
SCHIZOPHRENIA;
SOCIAL ADAPTATION;
TARDIVE DYSKINESIA;
ANTIPSYCHOTIC AGENTS;
CLOZAPINE;
DRUG RESISTANCE;
HUMAN;
PSYCHIATRIC STATUS RATING SCALES;
SCHIZOPHRENIA;
SCHIZOPHRENIC PSYCHOLOGY;
SUPPORT, NON-U.S. GOV'T;
SUPPORT, U.S. GOV'T, NON-P.H.S.;
SUPPORT, U.S. GOV'T, P.H.S.;
|
|
EID: 0026796022
PISSN: 05867614
EISSN: None
Source Type: Journal
DOI: 10.1093/schbul/18.3.515 Document Type: Article |
|
Times cited : (274)
|
|
References (0)
|
